PCN72 COST-UTILITY ANALYSIS OF GEFITINIB VERSUS DOCETAXEL IN A MEXICAN PUBLIC INSTITUTION
May 1, 2009, 00:00
10.1016/S1098-3015(10)73309-X
https://www.valueinhealthjournal.com/article/S1098-3015(10)73309-X/fulltext
Title :
PCN72 COST-UTILITY ANALYSIS OF GEFITINIB VERSUS DOCETAXEL IN A MEXICAN PUBLIC INSTITUTION
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)73309-X&doi=10.1016/S1098-3015(10)73309-X
First page :
Section Title :
Open access? :
No
Section Order :
734